Clinical Trials Directory

Trials / Unknown

UnknownNCT04058912

PTEN-AKT-FOXO3 Gene Expression Relation With Low-ovarian Reserve in Endometriomas

RELATIONSHIP OF LOW-OVER RESERVE WITH PTEN-AKT-FOXO3 GENE EXPRESSION IN THE PRESENCE OF ENDOMETRIOMAS

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Uludag University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers

Summary

In this study, we aimed to investigate the relationship between PTEN-AKT-FOXO3 gene expression and decrease in ovarian reserve in the presence of endometrioma and other benign ovarian pathologies.

Detailed description

It is known that the presence of endometrioma negatively affects ovarian reserve. The development of endometriosis and the effect of the presence of endometrioma on ovarian reserve due to decreased PTEN expression are considered. This study was designed to compare ovarian PTEN-AKT-FOXO3 gene expression and ovarian reserve in patients with underwent surgery caused by endometrioma and those who had ovarian pathology due to other benign causes and PTEN-AKT-FOXO3 gene expression level will be evaluated by RT-PCR analysis.

Conditions

Interventions

TypeNameDescription
GENETICPTEN-AKT-FOXO3 Gene ExpressionIn the patient and patient control groups, 0.5 mm tissue strip will be removed for pathology from the cyst wall removed during surgery. and tissue samples will be stored in phosphate buffered saline at -80 C and PTEN-AKT-FOXO3 gene expression level will be evaluated by RT-PCR analysis.

Timeline

Start date
2019-05-27
Primary completion
2020-05-27
Completion
2020-06-30
First posted
2019-08-16
Last updated
2019-08-16

Locations

2 sites across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04058912. Inclusion in this directory is not an endorsement.